Skip to main content

Global Cancer Research and Control Seminar Series

This seminar series features talks by researchers and cancer control experts working in global oncology. The seminars provide opportunities for discussion and collaboration around impactful and innovative work that addresses cancer morbidity and mortality worldwide.    

Upcoming Seminars

 

 

Past Seminars

The Challenge of Early Detection of Breast Cancer in Mexico

Thursday, January 13, 2022 | 10:00 a.m. ET 

 

photo of Dr. Karla Under Saldana

Karla Unger Saldaña, MD, MSc, DSc

Dr. Karla Unger-Saldaña is a Mexican National Council of Science and Technology (CONACYT) researcher working at the National Cancer Institute of Mexico in Mexico City since 2014. She is also currently a remote fellow in International Health (2020-2022) at the Takemi Program, Harvard School of Public Health. After her postgraduate studies in Health Systems, she worked for five years with a local NGO where she designed and operated programs to promote breast cancer awareness and facilitate access to screening in highly marginalized settings across Mexico. Her research has focused on understanding late diagnosis and delayed access to treatment of breast cancer in Mexico, where the majority of cases start treatment in advanced stages. Her findings suggest that the largest proportion of delay is not due to the patients’ postponement of seeking care but to quality problems and access barriers that hinder the diagnostic and referral processes after the patient’s first contact with medical services.

 

 

 

 

Advancing Tobacco Use Treatment in Viet Nam: Health Systems and Population-Based Research

November 2nd, 2021 | 9:00 a.m. ET

 

Donna Shelley, MD MPH

Donna Shelley, MD MPH

Drs. Donna Shelley and Nam Nguyen will present a community health center study and findings from an R21 grant award that developed a text messaging program. 

Dr. Donna Shelley is a Professor of Public Health Policy and Management, Vice Chair for Research, and Director of the Global Center for Implementation Science in the Department of Public Health Policy and Management at the New York University (NYU) School of Global Public Health (GPH). She is also Co-lead of the Epidemiology and Cancer Control Program for the NYU Perlmutter Cancer Center. Dr. Shelley has built a program of translational, population-based, and policy-relevant research that aims to optimize dissemination, implementation, and scale-up of tobacco use treatment in safety-net health care delivery systems in the US and Viet Nam. She applies implementation research methods to study the influence of organizational and individual-level factors on implementation of evidence-based tobacco policies and practices and tests strategies for addressing barriers to implementation in a wide range of settings, including health care systems, communities, and public housing.  Dr. Shelley received her medical degree from the Mount Sinai School of Medicine, and MPH in Health Policy and Management at Columbia University's Mailman School of Public Health.

Nam Nguyen, MD, DrPH

Nam Nguyen, MD, DrPH 

Dr. Nam Nguyen is the founder and Director of the Institute of Social and Medical Studies (ISMS), a research institute based in Ha Noi, Viet Nam, with expertise in conducting public health research to provide evidence to inform developing, planning, and implementing strategies, policies, and programs to advance public health in Viet Nam. Dr. Nguyen received his medical degree from Hanoi Medical University and his Master of Public Health and Doctor of Public Health degrees from Columbia University's Mailman School of Public Health Dr. Nguyen’s research interests include, but are not limited to HIV/AIDs, sexual and reproductive health, gender and sexuality, communicable diseases, non-communicable disease (NCDs), and tobacco cessation. He has served as Principal (PI) or Co-Investigator for more than 35 large-scale quantitative and qualitative studies employing a broad spectrum of research methodologies and with funding from a wide range of donors such as Atlantic Philanthropies, the Bill and Melinda Gates Foundation, FHI360, International Food Policy Research Institute, Population Council, PATH, the World Bank, USAID/PEPFAR, and the National Institute of Health (NIH). 

 

 

 

Introduction of HPV Testing and HPV Self-Collection in Argentina: Results From the Evidence

September 14th, 2021 | 9:00 a.m. ET

Global Cancer Research and Control Seminar Series - Introduction of HPV Testing and HPV Self-Collection in Argentina: Results From the Evidence

Silvina Arrossi, MSc, PhD, is a senior researcher at the National Council for Scientific and Technological Research (CONICET) and at the Centro de Estudios de Estado y Sociedad (CEDES), Argentina. From 2008-2018 she served as the Scientific Coordinator of the National Program on Cervical Cancer Prevention, Argentina, and since 2019 as a member of its Scientific Committee. Dr. Arrossi is the principal investigator of several national and international research projects aimed at improving the prevention of cervical cancer. Currently, she serves as a consultant to the World Health Organization in the area of cancer control program organization and management. In addition, she serves as a member of the American Association for Cancer Research (AACR) Regional Advisory Board for Latin America and of the “Initiative for a global data repository on Cancer Screening in 5 Continents (CanScreen5)” Advisory Board led by IARC-WHO. Dr. Arrossi also serves as an adviser of ministries of health of several Latin American countries.


Dr. Arrossi's main areas of research include the organization of cancer prevention and control programs, the analysis of social inequalities in access to health services, and the social and economic cost of cancer. Her publications include papers in peer-reviewed journals, book chapters, and programmatic materials.

 

The National Cancer Grid, India - Eliminating Disparities in Cancer Care 

July 13th, 2021| 9:00 a.m. ET

Global Cancer Research and Control Seminar Series - The National Cancer Grid, India

Dr. C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Mumbai. He serves on the Board of Directors of the Union for International Cancer Control (UICC). He is the convener for the National Cancer Grid, a large network of 244 cancer centres in India (https://tmc.gov.in/ncg). The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is also a visiting professor at the Division of Cancer Studies, King’s College London and the Institute of Cancer Policy, King’s Health Partners, London.

His clinical interests include the management of esophageal and lung cancers and minimally invasive surgery. He is the Principal Investigator in several investigator-initiated research studies including randomized trials on cancer screening, surgical techniques, neoadjuvant and adjuvant treatment of thoracic cancers. His broader research interests include cancer policy, health equity, value-based care and health services research. He has more than 200 peer-reviewed journal articles, abstracts and book chapters on various topics including thoracic oncology, clinical research methods, translational research, health equity, and cancer policy.

Prof Pramesh has strong interests in clinical trial designs, surgical trials, comparative effectiveness research, promoting collaborative research and cancer policy. He has completed the Post Graduate Diploma in Clinical Trials offered by the London School of Hygiene and Tropical Medicine, University of London. He is keen on promoting training in clinical research methods and conducts several courses on clinical research methodology, biostatistics and scientific writing. He serves on the advisory boards of several national and international research organizations and granting agencies.

 

Breast Cancer Survival in Sub-Saharan Africa

May 4th, 2021| 9:00 a.m. ET

Global Cancer Research and Control Seminar Series – Breast Cancer Survival in sub-Saharan Africa

Dr. Valerie McCormack and Mr. Steady Chasimpha are epidemiologists based at the International Agency for Research on Cancer (IARC) and London School of Hygiene and Tropical Medicine respectively. Their research is focused mostly on cancer epidemiology in sub-Saharan Africa, including on cancers contributing to excessive premature mortality in the region. This work includes contextual studies of the reasons – biological, societal and health systems – for low breast cancer survival as well as etiological research on esophageal cancer.

The African Breast Cancer Disparities in Outcomes study (ABC-DO) is a breast cancer cohort initiated in 2014 across 5 Sub-Saharan African countries and has quantified the factors that need to be tackled to avoid breast cancers. The study also provides unique information on quality of life and the intergenerational impact of cancer deaths.

 
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Global Cancer Research and Control Seminar Series was originally published by the National Cancer Institute.”